DiaMedica Therapeutics Inc.
DMAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401040
No open-market purchases or sales by DiaMedica Therapeutics Inc. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $87.8M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in DiaMedica Therapeutics Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- 0 vs. Q1 2024
- Shares held
- 5.06M
- +464.0K (+10.1%) vs. Q1 2024
- Total value
- $14.9M
- +$2.20M (+17.3%) vs. Q1 2024
- New holders
- 3
- 9 more added
- Sold out
- 3
- 9 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DMAC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 88 | $87.8M |
| Q1 2026 | 99 | $79.2M |
| Q4 2025 | 92 | $96.0M |
| Q3 2025 | 78 | $82.8M |
| Q2 2025 | 58 | $34.2M |
| Q1 2025 | 57 | $28.5M |
| Q4 2024 | 45 | $36.5M |
| Q3 2024 | 40 | $23.3M |
| Q2 2024 | 32 | $14.9M |
| Q1 2024 | 32 | $12.7M |
| Q4 2023 | 38 | $10.9M |
| Q3 2023 | 36 | $11.0M |
| Q2 2023 | 32 | $15.1M |
| Q1 2023 | 25 | $3.93M |
| Q4 2022 | 28 | $3.99M |
| Q3 2022 | 26 | $3.14M |
| Q2 2022 | 28 | $7.42M |
| Q1 2022 | 34 | $10.0M |
| Q4 2021 | 39 | $14.9M |
| Q3 2021 | 34 | $11.2M |
| Q2 2021 | 43 | $16.9M |
| Q1 2021 | 41 | $52.1M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding DiaMedica Therapeutics Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Toronto Dominion Bank | 24 | $71 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 183 | $540 | 0.00% | +183 | New |
| Federation des caisses Desjardins du Quebec | 230 | $679 | 0.00% | 00.0% | Unchanged |
| Legend Financial Advisors, Inc. | 1,000 | $2.95K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,056 | $3.00K | 0.00% | +211+25.0% | Added |
| TD Waterhouse Canada Inc. | 1,070 | $3.12K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,888 | $5.57K | 0.00% | −808−30.0% | Reduced |
| Advisor Group Holdings, Inc. | 2,055 | $6.06K | 0.00% | +1,055+105.5% | Added |
| Naples Money Management LLC | 2,978 | $8.79K | 0.01% | 00.0% | Unchanged |
| US Bancorp | 4,335 | $12.8K | 0.00% | 00.0% | Unchanged |
| Massmutual Trust Co FSB | 4,824 | $14.2K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 8,413 | $24.8K | 0.00% | −15,607−65.0% | Reduced |
| Magnolia Capital Advisors LLC | 10,000 | $29.5K | 0.02% | +10,000 | New |
| Charles Schwab Investment Management Inc | 13,251 | $39.1K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 15,091 | $44.5K | 0.00% | −147−1.0% | Reduced |
| BNP Paribas Arbitrage, SA | 15,200 | $44.8K | 0.00% | +700+4.8% | Added |
| Dimensional Fund Advisors LP | 16,959 | $50.0K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 17,500 | $51.6K | 0.00% | +17,500 | New |
| Stonebridge Capital Advisors LLC | 20,000 | $59.0K | 0.01% | 00.0% | Unchanged |
| Catalyst Financial Partners LLC | 38,457 | $113.4K | 0.02% | +2,190+6.0% | Added |
| Susquehanna International Group, LLP | 43,373 | $128.0K | 0.00% | −165,959−79.3% | Reduced |
| State Street Corp | 68,729 | $202.8K | 0.00% | +2,100+3.2% | Added |
| Morgan Stanley | 86,200 | $254.3K | 0.00% | −5,373−5.9% | Reduced |
| BlackRock Inc. | 105,303 | $310.6K | 0.00% | +1,933+1.9% | Added |
| Aristides Capital LLC | 106,333 | $313.7K | 0.13% | 00.0% | Unchanged |
| Northern Trust Corp | 120,389 | $355.1K | 0.00% | −7,430−5.8% | Reduced |
| Geode Capital Management, LLC | 236,888 | $699.0K | 0.00% | −2,347−1.0% | Reduced |
| Bleichroeder LP | 382,317 | $1.13M | 0.34% | +160,000+72.0% | Added |
| Paragon Associates & Paragon Associates II Joint Venture | 482,614 | $1.42M | 3.48% | −17,386−3.5% | Reduced |
| First Manhattan Co | 839,081 | $2.48M | 0.01% | −10,957−1.3% | Reduced |
| Vanguard Group Inc | 1,017,402 | $3.00M | 0.00% | +3,880+0.4% | Added |
| Cooperman Leon G | 1,400,000 | $4.13M | 0.17% | +516,377+58.4% | Added |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −24,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,926−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −175−100.0% | Sold out |